A series of stories that looks at the breakthroughs, setbacks, and overall status of vaccines and cures for hard-to-treat ...

Market SizeThe global genome editing market was valued at USD 5.5 billion in 2022 and is projected to grow at a CAGR of 13.9% ...

Genome editing with various CRISPR-Cas molecule complexes has progressed rapidly in recent years. Hundreds of labs around the ...

MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the ...

A research group led by Jacob Corn has just discovered that the use of AZD7648 has serious side effects. The study has just ...

Scientists in Asia and Africa are racing to discover hardier crop varieties using gene editing tools. But patent restrictions ...

Thanks to CRISPR, medical specialists will soon have unprecedented control over how they treat and prevent some of the most ...

Thanks to the revolutionary advancements in CRISPR technology, medical specialists are on the verge of transforming how we ...

Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.

Silvan Tuerkcan, an analyst from JMP Securities, has initiated a new Buy rating on Prime Medicine, Inc. (PRME).Pick the best stocks and ...

Ilya Finkelstein’s research focuses on improving gene editing, understanding DNA repair and finding disease treatments.